Illumina, Inc MiSeq Instruments Preventative Maintenance
ID: 25-000007Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH - CCBETHESDA, MD, 20892, USA

NAICS

Electronic and Precision Equipment Repair and Maintenance (811210)

PSC

MAINT/REPAIR/REBUILD OF EQUIPMENT- INSTRUMENTS AND LABORATORY EQUIPMENT (J066)
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source firm fixed-price contract to Illumina, Inc. for the preventative maintenance of MiSeq Sequencing Systems located in Bethesda, Maryland. This contract is crucial for ensuring the operational integrity of the equipment, which is essential for high-resolution Human Leukocyte Antigen (HLA) typing in transplant patient testing. Illumina, Inc. is the sole manufacturer and service provider for these systems, and their maintenance is necessary to prevent warranty invalidation and ensure accurate patient test results. Interested parties may express their interest by October 21, 2024, but the decision to not pursue competitive bids will be at the discretion of the government. For further inquiries, contact Emeka Onyejekwe at emeka.onyejekwe@nih.gov.

    Point(s) of Contact
    Files
    Title
    Posted
    The National Institutes of Health (NIH) intends to award a sole source firm fixed-price contract to Illumina, Inc. for preventative maintenance of MiSeq Sequencing Systems at their Bethesda, MD facility. This contract is necessary for ensuring that the equipment, critical for HLA typing in transplant patient testing, remains operational and compliant. Illumina, Inc. is the only authorized provider for maintenance to prevent warranty invalidation and guarantee instrument functionality. Under the Federal Acquisition Regulation (FAR) Part 13, the contracting officer has determined that only Illumina can fulfill this requirement. Interested parties may submit their interest by October 21, 2024, but the decision to not pursue competitive bids rests solely with the government. This acquisition underscores the NIH's commitment to maintaining high standards in patient care through reliable laboratory equipment maintenance.
    Lifecycle
    Title
    Type
    Similar Opportunities
    65--Illumina Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Heart, Lung, and Blood Institute (NHLBI), intends to award a non-competitive contract to Illumina, Inc. for the supply of "Illumina Reagents and Consumables" essential for various sequencing and genotyping systems. This procurement is driven by the unique operational needs of NIH-owned systems, as confirmed by market research indicating that only Illumina can provide the proprietary reagents necessary to maintain research integrity and support ongoing studies. The contract performance period is set from September 3, 2025, to September 2, 2030, and interested parties may submit capability statements for review by January 6, 2025; however, this is not a solicitation for proposals. For further inquiries, interested parties can contact Ethan J. Mueller at ethan.mueller@nih.gov or by phone at +1 301 496 2153.
    J--NICHD: Service: PacBio Sequel II Service Agreement
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Child Health and Human Development (NICHD), intends to award a sole source contract to Pacific Biosciences of California for a PacBio Sequel II Service Agreement. This procurement is essential for maintaining two advanced PacBio sequencers that are critical for NICHD researchers, ensuring their reliable operation while minimizing downtime and repair costs. The contract will cover one year of service, including preventive maintenance, software updates, remote diagnostics, and the provision of necessary reagents, with a performance period from January 11, 2025, to January 10, 2026, and the possibility of three option years. Interested parties are encouraged to submit their interest and capabilities by December 27, 2024, to determine if a competitive procurement process will be initiated. For further inquiries, contact Nicole T. Freid at nicole.freid@nih.gov or +1 301 480 6914.
    NOTICE OF INTENT TO SOLE SOURCE: Preventative Maintenance Services for Nikon CSU-W1 SoRa Spinning Disk Microscope
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), through its National Cancer Institute (NCI), intends to procure sole source preventative maintenance services for a government-owned Nikon CSU-W1 SoRa Spinning Disk Microscope, which is critical for imaging work at the NCI's Laboratory of Cancer Biology and Genetics. The procurement requires comprehensive maintenance services, including routine inspections, emergency repairs, and software updates, all performed by OEM-trained technicians to ensure compliance with manufacturer specifications and uninterrupted operation of this essential research equipment. Interested vendors must submit capability statements by December 30, 2024, and must be registered in the System for Award Management (SAM) to be considered for this firm fixed-price contract, which includes a 12-month base period and four option periods. For further inquiries, vendors can contact Lena Lee, Contract Specialist, at lena.lee@nih.gov.
    Global Life Sciences Solutions Preventative Maintenance Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a sole-source contract for preventative maintenance services for three Sepax Pro Cell Processing Systems used in cell therapy manufacturing and research. The contract will be awarded to Global Life Sciences Solutions USA LLC, the only vendor authorized to perform these services due to the proprietary nature of the equipment and the requirement for compliance with FDA regulations regarding critical equipment maintenance. The period of performance for this contract is set from January 27, 2025, to January 26, 2026, with interested parties encouraged to submit capability statements by December 28, 2024, to Sheri Eiri at sheri.eiri@nih.gov for consideration.
    Cytiva Sefia S-2000 Cell Processing Instrument Preventative Maintenance Services
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to award a sole source contract to Global Life Sciences Solutions USA LLC for preventative maintenance services on three Cytiva Sefia S-2000 Cell Processing Instruments located at the NIH Clinical Center in Bethesda, Maryland. The contract will cover unlimited service repair and preventive maintenance for these critical instruments used in cell therapy manufacturing and research, which are essential for compliance with FDA regulations regarding the maintenance of equipment used in drug product manufacturing. Interested parties capable of providing similar services may submit a capability statement by December 29, 2024, at 12:00 pm EST to Sheri Eiri at sheri.eiri@nih.gov for consideration in the procurement process.
    NOTICE OF INTENT TO SOLE SOURCE: Preventative Maintenance Service for Zeiss Confocal and Epifluorescence Microscopes
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Cancer Institute (NCI), intends to procure preventative maintenance and emergency services for fourteen government-owned Zeiss microscopes, which are critical for cancer research conducted by the Laboratory of Cancer Biology and Genetics. The procurement will be conducted on a sole-source basis with Carl Zeiss Microscopy, LLC, the original equipment manufacturer, due to its proprietary software and the necessity for authorized service technicians to ensure compliance with manufacturer specifications. This maintenance contract is vital for maintaining the operational functionality of the microscopes, which play a significant role in biological specimen analysis. Interested parties, particularly small businesses, are invited to submit capability statements by January 6, 2025, to be considered for potential competitive procurement. For further inquiries, contact Lena Lee at lena.lee@nih.gov.
    *UPDATED* NOTICE OF INTENT TO SOLE SOURCE: Preventative Maintenance Services for Various Government-owned Leica Imaging Equipment
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Cancer Institute (NCI), intends to procure sole-source preventative maintenance services for various government-owned Leica imaging devices critical to ongoing cancer research. The contract will encompass maintenance for seven advanced imaging systems, including confocal microscopes and a digital slide scanner, ensuring compliance with manufacturer specifications to support essential research activities. These devices are pivotal for analyzing cancer pathology and therapeutic responses across multiple NIH laboratories, making timely and expert maintenance vital to avoid significant downtime that could jeopardize research outputs. Interested parties, particularly small businesses, may submit capability statements by December 23, 2024, with all inquiries directed to Lena Lee at lena.lee@nih.gov.
    CHROMIUM IX/X AND VISIUM CYTASSIT ASSURANCE PLAN
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking to negotiate a sole-source contract with 10X Genomics, Inc. for a warranty and maintenance agreement for their Chromium X and CytAssist instruments. This procurement is critical as these instruments are essential for conducting advanced single-cell sequencing and spatial transcriptomics research, which supports the development of new diagnostics, therapeutics, and vaccines against human diseases. The maintenance agreement will ensure uninterrupted operation of these technologies, which are vital for NIAID researchers, and interested vendors must submit their capabilities statements via the NIAID electronic Simplified Acquisition Submission System (eSASS) by 12:00 PM EST on December 30, 2024. For further inquiries, vendors can contact Maliaka Pinkney at maliaka.pinkney@nih.gov or Jesse D. Weidow at weidowjd@niaid.nih.gov.
    66--NM SOUTHWESTERN NATIVE ARC MiSeq i100 Plus System
    Active
    Interior, Department Of The
    The U.S. Fish and Wildlife Service (FWS) intends to award a sole source contract for the purchase of a MiSeq i100 Plus System from Illumina, Inc. This procurement is necessary for the eDNA detection capabilities of the Service-wide Molecular Laboratory Network (MLN), requiring standard equipment and protocols that only Illumina can provide as the sole manufacturer and supplier. The contract will be awarded under the authority of FAR 6.302-1, which allows for procurement from only one responsible source. Interested parties who believe they can meet the requirements may submit a statement of capabilities to Dana Arnold at danaarnold@fws.gov by email only, as this opportunity does not constitute a solicitation for competitive quotes.
    MAINTENANCE AGREEMENT
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a non-competitive contract for a maintenance agreement for the Ingenia Elition XProtection MRI machine, crucial for the National Institute of Diabetes, Digestive, and Kidney Disease (NIDDK). The procurement aims to ensure the continuous operation and reliability of the MRI machine through a service agreement that includes preventative maintenance, priority service, and access to necessary spare parts. This contract is vital for maintaining the integrity and usability of the MRI, which is essential for ongoing research and clinical activities. Interested parties should contact Verne L. Griffin at verne.griffin@nih.gov or Michael L. Falzone at michael.falzone@nih.gov, with responses due by 11:00 AM EST on December 27, 2024, under a projected contract value not exceeding $250,000.